Longitudinal human studies focused on biomarkers, including tau imaging post-anesthesia, are necessary to determine whether anesthetic exposure affects tau pathology in tandem with cognition and to ascertain its consequences for AD risk and progression. This evidence concerns the gene MAPT and Alzheimer disease.